For example, a liquid reagent drop-in of CD22-APC in the free APC fluorescence channel of the DURAClone RE ALB panel could provide a baseline assessment of CD22 expression on B-ALL blasts, which would be useful for deciding on anti-CD22 targeted therapy in B-ALL patients. Here, APC is linked to acute lymphoblastic leukemia.